3 results
The primary objective of this study is to evaluate the effects of SYR-322 and SYR-322coadministered with pioglitazone HC1 versus placebo on postprandial triglycerides in subjectswith type 2 diabetes.
This trial will determine the relative incidence of CV outcomes compared to placebo forthe TZD class as a whole, rosiglitazone (RSG), and pioglitazone (PIO) when added to thetherapeutic regimen of a person with type 2 diabetes who has additional…
The purpose of this study is to compare the MR formulations with the IR formulation. It will be investigated to what extent the MR formulations of Ivabradine are tolerated. In addition, it will be investigated how quickly and to what extent the MR…